Table 2.
Univariate and multivariate analysis of serum alkaline phosphatase and γ-glutamyltransferase levels and overall survival before treatment
|
Project
|
Single factor analysis (95%CI)
|
P value
|
Multivariate analysis (95%CI)
|
P value
|
| ALP (> 135 U/L vs ≤ 135 U/L | 1.988 (1.313-3.008) | 0.001 | 1.766 (1.068-2.921) | 0.027 |
| GGT (> 45 U/L vs ≤ 45 U/L) | 2.816 (1.741-4.556) | 0.001 | 2.312 (1.367-3.912) | 0.002 |
| Cholinesterase (< 4300 U/L vs ≥ 4300 U/L) | 1.948 (1.328-2.857) | 0.001 | 1.312 (0.815-2.113) | 0.264 |
| ALT (> 40 U/L vs ≤ 40 U/L) | 1.716 (1.125-2.617) | 0.012 | 1.531 (0.933-2.511) | 0.092 |
| AST (> 35 U/L vs ≤ 35 U/L) | 1.479 (0.937-2.334) | 0.093 | 0.819 (0.483-1.390) | 0.460 |
| TBil (> 30 μmol/L vs ≤ 30 μmol/L) | 2.098 (1.338-3.288) | 0.001 | 1.202 (0.689-2.096) | 0.518 |
| Alb (< 40 g/L vs ≥ 40 g/L) | 1.274 (0.830-1.956) | 0.269 | 0.814 (0.502-1.319) | 0.403 |
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: γ-glutamyltransferase; 95%CI: 95% confidence interval.